HillSignal

FEMASYS INC

Total Raised
$30,000,000
Contracts
--
Patents
--
PAC Giving
--

Government Contracts & Awards

No recent government contracts or awards found.

Proprietary Tech & Patents

No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).

Form D Funding

Private Placement

Aug 10, 2026
$30,000,000Raised

Market Intelligence & News

No recent news or market intelligence found for this entity.

Congressional Trades in $FEMY

No disclosed congressional trades found in $FEMY.

Insider Trades (Form 4)

GRANTDirector

Eichenbaum Kenneth D.

880 shares Aug 12, 2026
GRANTDirector

Uzialko Edward R

880 shares Aug 12, 2026
GRANTDirector

Milnes Alistair

880 shares Aug 12, 2026
GRANTDirector

Larsen Charles

880 shares Aug 12, 2026
BUYChief Clinical-Medical Affairs

Mifek Jeffrey Gerald

$10,0003,125 shares Aug 12, 2026
GRANTChief Clinical-Medical Affairs

Mifek Jeffrey Gerald

6,250 shares Aug 12, 2026
BUYChief Technology Officer

Sipos Jeremy Alexander

$10,0003,125 shares Aug 12, 2026
BUYChief Operating Officer

Canning John Charles

$14,0004,375 shares Aug 12, 2026

Key People

Jeffrey Mifek

Related Person

Kathy Lee-Sepsick

Related Person

Dov Elefant

Related Person

Charles Larsen

Related Person

Alistair Milnes

Related Person

Kenneth Eichenbaum

Related Person

Edward R Uzialko

Related Person

Jeremy Sippos

Related Person

John Canninng

Related Person

Lee-Sepsick Kathy

Chief Executive Officer

BoardInsider

Elefant Dov

Chief Financial Officer

Insider

Sipos Jeremy Alexander

Chief Technology Officer

Insider

Canning John Charles

Chief Operating Officer

Insider

Mifek Jeffrey Gerald

Chief Clinical-Medical Affairs

Insider

Milnes Alistair

Director

BoardInsider

Uzialko Edward R

Director

BoardInsider

Eichenbaum Kenneth D

Director

BoardInsider

Larsen Charles

Director

BoardInsider

Political Giving

No disclosed PAC contributions found for this entity.

Factual Connections

Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.

Upgrade to Pro